This paper aims to identify the causal effect of smoking on body weight using data from the Lung Health Study, a randomized trial of smoking cessation treatments. We find evidence that quitting smoking leads to an average long-run weight gain of around 11-12 pounds, and that the drop in smoking in recent decades explains 14% of the concurrent rise in obesity. Semi-parametric models provide evidence of a diminishing marginal effect of smoking on weight, while subsample regressions show that the impact is largest for younger individuals, females, those with no college degree, and those with healthy baseline weights.
Introduction
In the last 40 years obesity 1 rates have steadily increased in the United States (US), rising from 13% in the early 1960s to 35% in 2011-2012 (Flegal et al., 1998 , Ogden et al., 2014 .
This rise in obesity has contributed significantly to increasing rates of diabetes, heart disease, and stroke (Mokdad et al. 2001 , Manson et al. 1990 , Rexrode et al. 1997 The inverse trends in smoking and obesity raise the question of whether they are causally related, in which case tobacco control policies may had the unintended consequence of contributing to the rise in obesity. Quitting or reducing smoking could increase body weight since nicotine can act as an appetite suppressant and metabolic stimulant (Pinkowish, 1999) .
In standard economic models of body weight (e.g. Philipson and Posner, 1999) , nicotine's appetite-suppressing properties could be seen as decreasing the marginal utility of food consumption, leading to less eating and therefore lower body weight. Stimulating the metabolism would mean more calories burned holding physical activity constant, again reducing weight.
On the other hand, smoking reduces lung capacity (Hedenstrom et al., 1986) , which could lead to weight gain by increasing the marginal disutility from exercise.
A large public health literature documents that individuals tend to gain weight following smoking cessation (e.g. Williamson et al. 1991 , Froom et al. 1998 , Klesges et al. 1989 , Wiseman et al. 1998 , French et al. 1994 . A 1990 U.S. Surgeon General review of 15 studies found that 58-87% of people who quit smoking gained weight, with the average gain being about four pounds (U.S. Department of Health and Human Services, 1990) . Some evidence also suggests that at least some of the weight gain is temporary (Chen et al., 1993; Mizoue et al., 1998) . However, such associational studies do not identify the causal effect of smoking on weight. Most of these studies do not include a comparison group of non-smokers or smokers who did not quit, meaning that the estimated effect of smoking cessation on weight gain could be confounded by the general tendency for individuals to gain weight with age. Even if a comparison group is used, associational studies are unable to control for the unobserved confounders -such as time preference or level of interest in one's health -which differ for never-smokers, quitters, and non-quitters.
The economics literature has attempted to move closer toward causality by examining the effects of plausibly exogenous sources of variation in economic factors that influence smoking on BMI. The results from this literature are mixed. Chou prices or tax rates are used as the measure of cigarette costs, whether time is modeled using a quadratic trend or time period dummies, and whether the difference between short-run and long-run effects is considered. A particular controversial issue is whether cigarette costs can actually be considered exogenous. Cigarette prices may depend on the demand for cigarettes, while high cigarette taxes may be more politically palatable in states where a relatively small percentage of the population smokes. Fletcher (2014) considers a different tobacco-control policy -workplace smoking bans -and finds evidence that smoking cessation induced by these bans increases BMI.
To our knowledge, the only paper that uses a randomized intervention to estimate the causal effect of smoking on weight is Eisenberg and Quinn (2006; hereafter EQ) . EQ use the Lung Health Study (LHS), which randomly assigned smokers to a comprehensive smoking cessation program and then tracked their health for five years. EQ do not actually use the LHS microdata, but instead take advantage of the fact that O'Hara et al. (1998) report differences between the treatment and control groups' average changes in weight and smoking status to compute a Wald instrumental variables (IV) estimate of the weight gain from quitting smoking. EQ find that quitting smoking leads to a very large average weight gain of 9.7 kg (21.4 pounds), about five times the magnitude typically found in the associational literature. There are reasons to suspect this magnitude is overstated. EQ use random assignment into the smoking cessation program as an instrument for "sustained quitting", which is defined as being a medically verified quitter in all five LHS follow-up waves. The IV strategy therefore requires the strong assumption that the program only affects weight through its effect on sustained quitting. However, in addition to helping some smokers quit immediately and permanently, the program may help others quit smoking in some but not all follow-up periods, and still others by reducing their number of cigarettes smoked per day even though they never quit entirely. To the extent that such partial quitting exists and influences BMI, EQ's estimated average effect of quitting smoking will be biased upwards.
We contribute to the literature on the effect of smoking on weight in several ways. First, we provide, in our view, the most reliable estimates to date of the average causal effect of quitting smoking on weight. We use the LHS microdata to exploit the randomized nature of the study while also constructing detailed smoking measures -such as cigarettes smoked per day and average carbon monoxide (CO) level over the entire five-year period of the studythat account for delayed or temporary quitting as well as smoking intensity. Our preferred estimates imply that quitting smoking leads to an average short-run weight gain of 1.5-1.7 BMI units, which translates to around 10-11 pounds at the average height. This magnitude is substantially larger than the typical estimates from the associational literature, but substantially smaller than EQ's estimate that uses randomization but relies on the "sustained quitting" measure. Our second contribution is to show that this causal effect persists after five years, contradicting the aforementioned results from associational studies that the weight gain from quitting smoking diminishes over time (Chen et al., 1993; Mizoue et al., 1998) .
Our long-run estimates of 11-12 pounds imply that the fall in smoking explains around 14% of the rise in BMI in recent decades. Our third contribution is to estimate a semi-parametric instrumental variables (IV) model that allows the data to determine the functional form of the relationship between smoking and BMI. We find evidence of a diminishing marginal effect, with additional smoking having little long-run effect on BMI beyond about a pack of cigarettes per day or a CO level of about 20 parts per million (ppm). Finally, we conduct subsample analyses by age, gender, education, and baseline BMI and find that on average younger individuals, females, those with no college degree, and those with healthy baseline BMI levels gain the most weight in response to smoking cessation.
Data
This section provides a brief introduction to the LHS, with an emphasis on the information most relevant for our paper. O'Hara et al. (1993, 1998 ) provide a more detailed discussion of the LHS, and further information is also available online at https://www.clinicaltrials.gov.
The purpose of the LHS was to observe changes in the severity of chronic obstructive pulmonary disease (COPD) among smokers. The study consisted of 5887 smokers with initial ages between 35 and 59. Recruitment started in 1986 and ended in 1989. The clinical trial ended in 1994. To be eligible for selection, potential participants had to show signs of mild lung function impairment, have no history of certain medications, consume less than 25 drinks per week, and have no severe illnesses or chronic medical conditions. Each year all participants were extensively interviewed individually at a medical clinic near the residence of the participant (no more than 75 miles away from the participant's permanent residence).
The data therefore consist of the baseline period (1989) plus five annual follow-up periods (1990 through 1994) . Attrition was relatively low, as 5,297 individuals remained in the sample in the final wave. The attriters included 315 participants who died during the study period.
Participants were randomly assigned into three different groups: two treatment groups and one control group. Both treatment groups received a special intervention (SI) consisting of free nicotine gum, an intensive quit week, and frequent contact with support personnel with invitations to bring a spouse or relative to the meetings. The only difference between the two treatment groups is that, in addition to the SI, one group received an inhaled bronchodilator (SI-A) while the other received an inhaled placebo (SI-P). Most of the intensive intervention treatments were completed within the first 4 months of the study. The control group referred to as the usual care (UC) group received no intervention and members continued to use their own private sources for medical care.
The LHS collected information about weight, height, smoking behavior, family smoking habits, health status, and demographic characteristics. Weight and height were measured by medical staff at the participants' clinic visits, so our BMI measure is not susceptible to the concern about measurement error that is common in the economics of obesity literature. 2 The data contain self-reported smoking information as well as CO test results. We consider three different measures of smoking: a dummy variable for whether the respondent currently smokes (clinically measured through the CO test), number of cigarettes typically smoked per day (self reported), and CO level in ppm. We also utilize the LHS' information on education (dummies for high school graduate, some college, and college graduate), gender (dummy for male), age (years), and marital status (dummy for married) as controls. Note that we do not control for race/ethnicity because 97% of LHS participants were white. Our sample is therefore not representative of the overall population of US smokers along this dimension. Table 1 presents descriptive statistics for the three groups at the time of randomization.
Average cigarette consumption was roughly 30 cigarettes per day, average CO level was about 26, and the average respondent was just slightly overweight. The summary statistics for all variables are very similar across the three groups, indicating the randomization was successful. Sharp decreases in cigarette smoking, smoking status and CO level are evident for both treatment groups in the first year after the intervention. The decrease in smoking for the control group is much more moderate. Average BMI is trending upward for all three groups, but the two treatment groups experience much sharper increases in BMI than the control group in the first year. The graph therefore suggests both that the intervention was effective in reducing smoking and that smoking reduces BMI. We next use econometric methods to estimate the magnitude of these effects.
Econometric Analyses
Our econometric objectives are to identify 1) the average short-and long-run causal effects of quitting smoking on weight gain, 2) how the effect of smoking on weight changes across the smoking distribution, and 3) how the effect of smoking on weight varies by demographic characteristics and baseline BMI. We begin by using parametric regressions to answer the fist question and running falsification tests to evaluate the validity of the models. We then conduct semiparametric estimation allowing for a flexible relationship between smoking and weight to address the second question. Next, we answer the third question with subsample analyses. Finally, we address issues related to the generalizability of the results and show why our results differ from those of EQ.
Average Effects

Short Run
We begin by aiming to identify the average causal effect of quitting smoking on weight gain with a series of parametric regressions. Economists typically consider body weight to be a capital stock. Individuals start with an exogenous endowment of weight that changes over time due to depreciation as well as "investments" that take the form of caloric intake or expenditure. In the LHS, weight at the end of the first follow-up year can therefore be modeled as a function of weight at baseline and investments -such as smoking -in year one.
This leads to the model
where bmi i1 is individual i's BMI at the end of year 1, bmi i0 is BMI at the beginning of the study (year 0), S i1 is smoking in year 1, X i is a vector of demographic controls that are assumed to be constant over time since they are only available for the baseline wave, and ε i1 is period 1's error term. β 2 , the coefficient of interest, gives the short-run association between smoking and weight. We estimate the OLS model given by (1) as well as an IV model that uses the randomized treatment assignment to instrument for S i . The first stage of the IV model is given by
where si a i and si p i reflect whether the individual was assigned into the SI-A or SI-P treatment group, respectively. The second stage of the IV model is identical to (1) except it replaces S i1 with the predicted value generated by (2) . In the IV model, We define S i1 three different ways: a dummy for smoking cessation, number of cigarettes smoked per day, and CO level. We next discuss these three smoking variables.
The first smoking measure is a dummy equal to one if and only if individual i was a medically validated non-smoker at the end of year one. We consider this to be a naive measure of smoking because it ignores variation in smoking intensity among smokers. This could lead to an overstatement of the average weight gain from quitting smoking estimated by IV models. When a quit dummy is used as the smoking measure, the IV estimator effectively scales the difference in BMI between the treatment and control groups by the difference in smoking cessation rates between the two groups. The validity of this estimator therefore hinges on the assumption that the randomized intervention only affected the BMIs of people who fully quit smoking. To the extent that the intervention also affected the BMIs of those who cut back on smoking but did not quit entirely, the difference in BMI will be scaled by too small a number and the resulting IV estimate will be too large. (This point is central to our critique of EQ, and we will discuss it in more detail in Section 3.5.)
Our second smoking measure is therefore self-reported number of cigarettes smoked per day, with a value of zero assigned to those who reported quitting. This measure incorporates both reducing smoking and quitting entirely and therefore is not susceptible to the above criticism. In order to make the results using cigarettes per day comparable to β 2 from the regressions using the smoking cessation dummy, we need to compute an implied average weight gain from quitting smoking. Since the best way to do this is not immediately obvious, we consider several possibilities. First, we use the average weight that would be gained if all individuals in the sample switch from their baseline number of cigarettes to none. We do this by multiplying the coefficient estimate on the cigarettes smoked per day variable by each individual's number of cigarettes smoked at baseline, and then taking the average across all individuals. Formally, this means we compute
is cigarettes smoked per day and i indexes the N observations. Second, we use the same formula but average over only those individuals who actually quit smoking. Third, we only average over quitters from the treatment groups. Fourth, we compute the effect of quitting smoking from the sample mean baseline smoking level, i.e. β 2 cigday i0 . Fifth and sixth, we again compute β 2 cigday i0 but using only quitters, and quitters from the treatment group, respectively. The estimated average weight gain from quitting smoking is similar using all six approaches, so we only report the results using the first method: averaging the predicted effects across all individuals. Results from the other approaches are available upon request.
Key limitation with cigarettes per day is its self-reported nature. At issue for the validity of our IV estimates is not whether cigarettes per day are reported with error, but whether this error is correlated with treatment status. It is not obvious that this is the case, but it is possible that, for instance, being assigned into the treatment group creates more pressure to report progress toward smoking cessation, leading to differentially large reporting error among the treatment group. Alternatively, perhaps reporting error simply rises with number of cigarettes smoked per day, in which case we would expect the amount of error in the followup periods to be highest among the control group.
We therefore also utilize a third smoking variable that is both clinically measured and incorporates both the intensive and extensive margins of smoking: CO level from a test conducted during the follow-up interview. Using the CO regression estimates to compute the average weight gain from quitting smoking is somewhat more complicated than using cigarettes smoked per day since even non-smokers generally have a positive CO level. We 
Note that CO levels are only available at baseline for 922 individuals, so our average effect is computed using only this portion of the sample (though our regressions still utilize the full sample). We doubt that this limitation is of consequence since reported numbers of cigarettes smoked per day at baseline are virtually identical for those with missing baseline CO levels and those with non-missing levels. We have also considered analogs of the other five approaches to computing the average effects of quitting smoking discussed above and verified that, as with cigarettes per day, the results are robust.
While using CO levels solves the probability of reporting error, it should be noted that it is not immune to all sources of measurement error. In particular, it only reflects smoking in the past couple of days. Therefore, for some people self-reported number of cigarettes smoked per day could actually be more indicative of typical smoking behavior than clinically measured CO. Consequently, we take an agnostic view about which measure is preferred and present the results for both alongside each other throughout the paper. 3
Long Run
The above specifications estimate the short-run causal effect of smoking on BMI. We also aim to identify the long-run effect by asking how smoking across all five follow-up waves affects BMI at the end of the study (year five). Comparing the short-and long-run effects is important since evidence from the associational public health literature suggests that at least some of the weight gained after quitting smoking is temporary (Chen et al., 1993; Mizoue et al., 1998) . Ideally, we would like to estimate
where bmi i5 is individual i's BMI at the end of year 5 and S it is smoking in year t. However, the need to utilize IV estimation prevents us from allowing separate coefficients for each of the five smoking variables, as this would require five instruments. In other words, in order to operationalize an IV model we need to compress the five years of smoking information into a single variable S i . The easiest way to do this is to take a simple average across the five years:
However, this approach assumes that smoking in each of the five periods has the same effect on weight. To the extent that weight is a depreciating capital stock, we might expect smoking in more recent years to have a larger effect on BMI than smoking in more distant years. We therefore also estimate models defining S as a weighted rather than simple average of quit status in the five follow-up years:
Since we do not have a sufficient number of instruments to credibly estimate the depreciation rate δ, we simply try several plausible values: 0.05, 0.1, 0.15, 0.2, 0.25, and 0.3. In all our regressions, the coefficient estimate on the baseline BMI variable will barely be below one, so we consider it probable that the "true" value of δ is toward the low end of this range; i.e. there is little reason to consider values of δ above 0.3.
We estimate equation (3) using both OLS and IV, with si a i and si p i again serving as the instruments. We again use the three different measures of S it : smoking cessation, cigarettes smoked per day, and CO level. For the cigarettes per day and CO regressions, we compute implied average effects of quitting smoking in the same manner as the short-run specifications. estimates are 31% and 22% smaller than the 13.9 pounds we obtained using the quit dummy. This is consistent with our prediction that neglecting to account for smoking intensity leads to an exaggerated IV estimate of the average weight gain from quitting smoking.
Results
The last three columns turn to the long-run estimates. The key result is that the longrun effects are slightly stronger than the short-run effects. This is an important result, as it contradicts the prior associational evidence that at least some of the weight gain from Finally, the first-stage estimates in Panel B of Table 2 show that the treatment was effective in reducing smoking. In the short run, being assigned into the SI-A or SI-P groups increased the probability of quitting by 27-28 percentage points while decreasing cigarettes smoked per day by 11-12 and CO level by 8 ppm. In the long run, SI-A or SI-P assignment increased the fraction of the five follow-up years quit by 0.21 while decreasing average cigarettes per day by 9 and average CO by 6-7 ppm. The treatment variables are all highly significant in the first stage and the F-statistics from the test of their joint significance are easily large enough to conclude that they are sufficiently strong instruments. Also noteworthy is the fact that there is essentially no difference in the coefficient estimates for the two treatment variables; in other words, the inhaled bronchodilator given to the SI-A group did not influence smoking. This also means that, though our IV model is technically overidentified, the instruments are not sufficiently distinct to make an overidentification test informative or to consider instrumenting for two endogenous variables.
Falsification Tests
We next conduct falsification tests to support our contention that the IV results using cigarettes per day and CO are more credible than those using the quit dummy. In our IV models, the identifying assumption is that the randomized treatment only influences BMI via the smoking variable. Our falsification tests evaluate this assumption by asking whether the instruments influence the BMIs of individuals who did not change their smoking habits during the sample period, according to each smoking measure. A significant association would provide evidence that the randomized intervention influenced BMI through pathways other than the particular smoking measure, invalidating the causal interpretation of the corresponding IV estimate. For the quit measure, we restrict the sample to those with values of 0, meaning those who smoked in the first follow-up wave for the short-run analysis and those who smoked in all five follow-up waves for the long-run analysis. For the continuous smoking measures, there are obviously very few individuals with literally no change in smoking across the sample period (i.e. the exact same number of cigarettes smoked per day/CO level in the baseline period as in the follow-up waves), so a judgment call is required as to what magnitude change in smoking should be considered "meaningful". We report results restricting the sample to those whose post-treatment level of smoking is within 25% of their baseline level; results using neighboring cutoffs are similar. Using these subsamples, we estimate the reduced-form version of the short-and long-run IV models; i.e. we regress BMI on the two treatment variables plus the controls.
Ex ante, our prediction is that the binary quit measure will perform the worst in the falsification tests since it leaves people in the sample who did actually experience a meaningful change in smoking but did not quit entirely. Note that it is not obvious that the falsification tests will produce null results even for the smoking measures that incorporate intensity, though, since it is conceivable that the treatment could affect BMI through pathways other than smoking. For instance, perhaps being exposed to an intensive health-related intervention might increase some people's level of general health consciousness, which could lead to improved health behaviors along other dimensions besides smoking. The falsification tests are therefore important in assessing whether even our most conservative estimates of the effect of smoking on weight can be given a causal interpretation. Table 3 reports the results. The left half of the table presents the results from the shortrun falsification tests ("effects" of the treatment dummies on year 1 BMI for those with unchanged smoking status) while the right half shows the long-run results (year 5 BMI).
For comparison purposes, the first column of each half of the table presents the reducedform results for the full sample. The remaining three columns of each half include those with no meaningful changes in the quit, cigarettes per day, and CO variables, respectively.
The sample sizes in the tests based on cigarettes per day are smaller than those using quit status simply because more individuals are excluded as the measure of smoking becomes more comprehensive. The sample sizes in the two columns using CO are very small because, as discussed previously, much of the sample is missing baseline CO information, preventing the calculation of the percentage change. The falsification tests using cigarettes per day are therefore much more highly powered -and consequently more informative -than those using CO.
The columns labeled "full sample" show that, in both the short and long run, the reducedform effects of the two treatment variables on BMI are between 0.54 and 0.61 before excluding any observations. Dropping those who quit smoking reduces the magnitude of these effects by about half, but significant effects of 0.21-0.28 remain. There is therefore clear evidence that the intervention affected BMI through a pathway besides quitting smoking, implying that the IV estimates using quitting smoking are too large. The falsification test results are much more favorable if we also exclude those with meaningful (>25%) changes in smoking intensity. In the two regressions that use cigarettes per day, the coefficient estimates for the treatment variables are small (between -0.014 and 0.091) and highly statistically insignificant.
There is therefore no evidence that the exclusion restriction in the IV model is violated if cigday is used as the smoking measure. Excluding on the basis of changes in CO also leads to highly insignificant effects, with three being negative (the opposite direction of the fullsample relationship) and one positive. The estimates are imprecise due to the small sample size, so these results are not as compelling as those using cigday, but the lack of a clear pattern is at least somewhat reassuring. To summarize, the results in this section suggest that while the IV results using the quitting indicator are contaminated by an alternative effect, the results using both number of cigarettes and CO levels are more reliable.
Semi-Parametric Estimation
An issue with the parametric regressions for cigday and CO is that they assume that smoking intensity affects BMI linearly. This is a strong assumption, as it seems likely that there is either a non-linear dose-response effect of nicotine on metabolism/appetite or a non-linear effect of metabolism/appetite on weight-related behaviors. While it is not clear that this will bias estimates of the average weight gain from quitting smoking, such a restrictive functional form is likely to lead to systematically inappropriate predictions for at least some individuals. Moreover, given the complicated chain of biological and behavioral pathways through which smoking influences BMI, the nature of the non-linearity is not clear ex ante. In other words, it is not obvious that the non-linearity could be captured through simple approaches such as logarithmic or quadratic specifications. We therefore next estimate a semi-parametric model that allows the data to determine the functional form of the relationship between smoking and BMI. Specifically, we implement Robinson's (1988) semi-parametric double residual estimator with local smoothing. This approach allows us to model the expectation of the dependent variable at every point on the distribution of the independent variable, thereby enabling the prediction of the weight gained (or lost) from switching from any level of smoking to any other level. 5 Semi-parametric IV models can be estimated using a control function approach (Blundell and Powell, 2004; Lee, 2007) . The first stage takes the same form as equation (2) . The second stage differs from equation (1) in two ways. First, it does not specify the functional form for the smoking measure. Second, rather than using the predicted value of the smoking variable from the first-stage regression, the second stage includes the residual from the first stage as a regressor. 6 The second stage short-run regression can therefore be expressed as
where S is either cigday or CO and µ is the first-stage residual. The second stage long-run regression is similar but replaces bmi i1 with bmi i5 and S i with the average smoking measures discussed previously.
The estimation was conducted using the Stata program "semipar" by Deparsy and Verardi (2012). The first step is to estimate E(bmi|S), E(µ|S) and E(X|S), which are approximated by the predicted values bmi, µ, and X by a kernel weighted local polynomial regression. The second step is to form the residuals µ 1 = bmi− bmi, µ 2 = X− X, µ 3 = µ− µ.
Then the coefficients β 0 , β 1 , β 2 , and β 3 , representing the relationships between the independent variables and BMI, are estimated by regressing µ 1 on µ 2 and µ 3 . Thus, all parameters in equation (6) are identified except the relationship between cigarette consumption and BMI.
The last step is, therefore, to identify this relationship with a non-parametric regression of cigarette consumption on the predicted BMI residual,bmi i1 − β 0 − β 1 bmi i0 − β 2 X i − β 3 µ i . This relationship is estimated at every level of cigarette smoking, allowing independent marginal effects. The idea behind this strategy is to estimate the non-parametric cigarette function by the residual variation that is unrelated to the parametric independent variables.
We calculate the average effect of quitting smoking on BMI using the semi-parametric estimates as follows. When using the cigarettes smoked per day variable, we first calculate the change in predicted weight from switching from the number of cigarettes smoked at baseline to zero. We then take the average of these predicted changes across all individuals in the sample. The process for the CO variable is similar; the only difference is that we compute the predicted effect of switching to the average CO level for non-smokers of 3.61 ppm, as opposed to zero.
In semi-parametric estimation, the confidence interval becomes very wide at extreme values where there are very few observations. We therefore drop the top 1% of the smoking distribution, which means those who smoke more than 50 cigarettes per day on average across the five follow up years and those with average CO levels of over 50 ppm. We doubt that this restriction is consequential, since if we drop the same individuals in the parametric regressions the results (available upon request) remain similar. Figures 2 and 3 present the short-run semi-parametric IV results for cigday and CO, respectively. The graphs display both the point estimates for each integer level of smoking and the 95% confidence intervals. Figure 2 shows that the short-run relationship between cigarettes smoked per day and BMI is highly nonlinear. Specifically, smoking has a diminishing marginal effect on BMI throughout most of the distribution, with the shape of the curve being approximately quadratic. Quitting smoking from levels of 10, 20, 30, and 40 cigarettes per day is predicted to lead to weight gains of 1.22, 1.58, 1.66, and 1.94 BMI units, respectively. Most of the effect of smoking on weight therefore appears to occur at levels below 20 cigarettes per day. Taken literally, this would suggest that heavy smokers could cut back to a pack a day without fear of substantial weight gain. Figure 3 shows that the short-run effect of CO on BMI is less obviously non-linear than the effect of cigarettes per day. The curve is somewhat flat at very low levels of CO -specifically two to five ppm -but recall that even non-smokers often have non-zero CO so changes at such low levels probably do not reflect changes in smoking behavior. Starting at five ppm, the graph begins to take a quadratic shape, but unlike the graph for cigarettes per day we do not observe a complete leveling off until the far right tail of the distribution. The average effects of quitting smoking on BMI implied by these semi-parametric graphs are generally similar to those from the parametric specifications. Using cigarettes per day, the average effect of quitting is 1.67 BMI units in the short run and 1.93 in the long run, compared to 1.52 and 1.91 from the corresponding parametric regressions. For CO, the average effect is 1.80 in the short run and 1.99 in the long run, compared to the parametric regressions' estimates of 1.33 and 1.81. The results presented in this section suggest that the marginal effect of smoking on weight is likely to be modest for levels of smoking above 20 cigarettes a day, which would be impossible to detect using linear specifications.
Subsample Analyses
We next conduct subsample analyses to evaluate whether the effect of smoking on BMI differs by age, gender, education, or baseline BMI. Heterogeneous effects could occur because of differences in either the biological effects of nicotine on appetite or metabolism or the behavioral responses to these biological effects. Given the complicated nature of these relationships, we make no ex ante predictions about the patterns of heterogeneity. For age, we split the sample into three groups: those under 45, 45-54, and 55 and over at baseline.
We use these splits because there are no individuals under 35 or over 64 in the LHS. For education, we consider subsamples of those with no college education, some college, and a
four-year college degree or greater. There are not enough individuals with less than a high school degree or greater than a college degree to enable further stratification. For baseline BMI, we are interested in whether quitting smoking leads to larger weight gains among those who were already at risk of weight-related ailments prior to the intervention. We therefore split the sample into those with healthy weights at baseline (BMI<25) and those who were already overweight or obese (BMI≥25). degree. There is therefore some evidence of a small reduction in the effect of smoking on weight as education rises, with the largest gap being between those without a college degree and those with a degree. Perhaps education enables individuals to limit weight gain through an improved understanding of nutrition and exercise. Alternatively, education is correlated with income, and additional income may enable the purchase of healthier foods, gym memberships, or over-the-counter products that can help counteract weight gain. Finally, the average weight gain from quitting smoking is 1.98-2.05 BMI units for people with healthy baseline BMI levels compared to 1.7-1.82 for those who started the study overweight or obese. This result suggests that individuals who are at higher risk of health consequences from weight gain take more steps than others to limit the amount of weight gained after smoking cessation.
In all, though, perhaps the most striking results from Table 4 is that, while some heterogeneity appears to exist, the overall amount of heterogeneity is relatively small. Negative and highly significant effects of smoking on weight are evident for all subsamples. The smallest average effect of quitting smoking on BMI from any specification (55 and over, parametric, CO) is a still sizable 1.33. The lack of substantial heterogeneity in the effect within the sample provides perhaps some assurances that the results are generalizable outside the sample.
The next section evaluates the generalizability issue in more detail.
External Validity
We next perform some checks related to external validity. One obvious concern about the generalizability of the results is that the LHS was conducted in the early 1990s, raising the question of the relevance for current policy debates. (With that said, the frequently cited associational estimates are from studies using data that are generally as old or older.)
Another concern related to generalizability is that the LHS' participants are not a random sample of smokers: participants had to desire to quit smoking, have mild (but not major) lung function impairment, and live within reasonable proximity of the locations for followup visits. As discussed in the Data section, the end result was a sample that was almost exclusively white (97%) and exclusively middle-aged (starting age 35-59, ending age 40-64).
We attempt to at least somewhat alleviate these concerns by conducting additional analyses with the National Health Interview Survey (NHIS), a large nationally representative survey conducted annually by the Centers for Disease Control and Prevention. The NHIS contains self-reported data on smoking, weight, and height, along with the same control variables used in our LHS analyses (except for baseline BMI, since the NHIS is not a panel).
We use the NHIS to see if the association between cigarettes smoked per day and BMI varies along the dimensions of the generalizability issues: time period, race, and age. Obviously a causal analysis is not possible with the NHIS, but verifying that the association between smoking and weight is not particularly unique among the LHS population should provide at least some assurance that the causal effect is not likely to be unique either. We first estimate in order to evaluate the implications of the lack of representativeness by age. 8 Table 6 reports the results. The first column shows that, in the sample most comparable to the LHS, each additional cigarette smoked per day is associated with a reduction in In sum, though there is likely some heterogeneity across age, race, and time, these results provide at least some assurance that the lack of representativeness of the LHS is not driving 
Reconciling Our Results with Prior Literature
We close our empirical analysis by reconciling our results with those of EQ, who used previ- show that our finding of a considerably smaller effect can be attributed to our use of more comprehensive smoking measures.
We replicate EQ by computing a Wald IV estimate of the form
where subscript one indicates the treatment group (combination of the SI-A and SI-P groups) and zero the control group (UC). bmi 1 and bmi 0 are average BMIs among the treatment and control groups, respectively, at the end of the study period (year 5). quit represents EQ's measure of quitting smoking, called "sustained quitting," which is a dummy variable equal to one if and only if the individual was a medically verified non-smoker in all five follow-up waves. This is a very stringent measure, as anyone who smokes any amount in any of the five follow-up years is classified as a non-quitter.
The validity of the Wald estimator hinges on the assumption that the intervention only affected the weight of individuals for whom quit = 1. To the extent that the intervention also affected the weight of any other individuals (i.e. those with quit = 0), the denominator will effectively be too small. The observed difference in average weight between the treatment and control groups will therefore be scaled by too small a number, and the estimated effect of quitting smoking on weight will consequently be overstated. We suspect that the Wald estimator's identifying assumption is violated since there are two types of individuals categorized by EQ as having quit = 0 whose smoking behavior (and therefore weight) likely responded to the intervention to at least some extent.
The first type consists of those who quit smoking for part but not all of the 5-year followup period. If, for instance, someone quit smoking for the first two years, relapsed in year three, and then quit again for years four and five, this person is not classified as a quitter by EQ, but it seems likely that they would have gained almost as much weight as someone who quit for all five years. There are 1114 people in the treatment group who quit smoking in at least one follow up wave but were not sustained quitters. Therefore, not accounting for this group has the potential to substantially impact the results.
The second type consists of those who reduced smoking but did not quit entirely. Given the highly addictive nature of cigarettes, it seems likely that there are at least some people who were able to cut back on their cigarette intake as a result of the intervention but were unable to quit completely. Indeed, among those in the treatment group who never quit in any of the five follow-up waves, average cigarettes smoked per day still fell from 31 to 22.
There is no reason to suspect that the biological pathways through which smoking affects weight occur only along the extensive margin of smoking, so people who cut back on smoking would likely experience at least some amount of weight gain. Additionally, some people may also be a blend of the two types; e.g. someone who responds to the intervention by gradually cutting back on smoking until successfully quitting at the end of the third year.
After replicating EQ's results using the "sustained quitting" variable, we then re-compute the Wald estimate using our more nuanced long-run smoking measures discussed earlier in Section 3.1.2. Our "average quitter" measure addresses the issue of people who quit in some but not all follow-up years. The average cigarettes per day and average CO variables also address the issue of cutting back but not quitting entirely. Table 7 are quite similar to those from our preferred long-run specifications in Table 2 , we conclude that the difference between our results and those of EQ is due to the different smoking measures rather than our use of a covariateadjusted regression model in Table 2 . This is not surprising given the randomized design.
Note, however, that the standard errors are lower in Table 2 , so including covariates is still beneficial in that it improves the precision of the estimates.
Conclusion
This 
